Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Silexion Therapeutics Corporation (SLXNW)
Silexion Therapeutics Corporation (SLXNW) Actualités

SLXNW

Silexion Therapeutics (SLXNW)

Silexion Therapeutics Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SLXNW

1

Date	Heure	Source	Titre	Symbole	Société
22/11/2024	22h34	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SLXNW	Silexion Therapeutics Corporation
22/11/2024	22h30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLXNW	Silexion Therapeutics Corporation
20/11/2024	12h15	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:SLXNW	Silexion Therapeutics Corporation
14/11/2024	14h30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SLXNW	Silexion Therapeutics Corporation
13/11/2024	22h05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SLXNW	Silexion Therapeutics Corporation
31/10/2024	22h24	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:SLXNW	Silexion Therapeutics Corporation
22/10/2024	15h02	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SLXNW	Silexion Therapeutics Corporation
17/10/2024	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SLXNW	Silexion Therapeutics Corporation
10/10/2024	23h00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SLXNW	Silexion Therapeutics Corporation

Showing the most relevant articles for your search:NASDAQ:SLXNW

1

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales